Coronavirus (COVID-19) Advocacy
The ADA is lobbied Congress and the administration to protect dental patients and staff who are providing urgent and emergency care during the COVID-19 pandemic. The ADA is also lobbed to help dental practices stay viable during (and following) prolonged periods of reduced hours or closure. Visit ada.org to learn more about the Coronavirus (COVID-19) advocacy efforts.
ADA urges evidence-based approach in EPA fluoride review
Jun 12, 2025
The ADA is urging the EPA to incorporate several evidence-based studies in any upcoming review of the science on the safety of fluoride.
https://adanews.ada.org/ada-news/2025/june/ada-urges-evidence-based-approach-in-epa-fluoride-review-1/
